CVS officials say Sovaldi pricing in line with history, but unsustainable

July 21, 2014 5:25 PM

5 0

CVS officials say Sovaldi pricing in line with history, but unsustainable

July 20, 2014, 3:36 PM ET

Gilead Sciences’ controversial $1,000-a-day Sovaldi pill is priced in line with previous treatments for Hepatitis C, but the nation’s health-care system likely won’t be able to handle that kind of sticker shock, and competition probably will bring down that price tag in coming months and years.

Read more

To category page

Loading...